SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ana Bernal-Chico, Manuel Canedo, Andrea Manterola, María Victoria Sánchez-Gómez, Alberto Pérez-Samartín, Rafael Rodríguez-Puertas, Carlos Matute, Susana Mato, Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo, Glia, 2015, 63, 1
  2. 2
    Gabriele C. DeLuca, Richard L. Yates, Harry Beale, Sarah A. Morrow, Cognitive Impairment in Multiple Sclerosis: Clinical, Radiologic and Pathologic Insights, Brain Pathology, 2015, 25, 1
  3. 3
    Zhihong Chen, Jacqueline T. Chen, Matthew Johnson, Zachary C. Gossman, Megan Hendrickson, Ken Sakaie, Clarissa Martinez-Rubio, John T. Gale, Bruce D. Trapp, Cuprizone does not induce CNS demyelination in nonhuman primates, Annals of Clinical and Translational Neurology, 2015, 2, 1
  4. 4
    Don H Mahad, Bruce D Trapp, Hans Lassmann, Pathological mechanisms in progressive multiple sclerosis, The Lancet Neurology, 2015, 14, 2, 183

    CrossRef

  5. 5
    Eduardo Gascon, Kelleen Lynch, Hongyu Ruan, Sandra Almeida, Jamie M Verheyden, William W Seeley, Dennis W Dickson, Leonard Petrucelli, Danqiong Sun, Jian Jiao, Hongru Zhou, Mira Jakovcevski, Schahram Akbarian, Wei-Dong Yao, Fen-Biao Gao, Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia, Nature Medicine, 2014, 20, 12, 1444

    CrossRef

  6. 6
    Jae Lee, Kasra Taghian, Steven Petratos, Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?, Acta Neuropathologica Communications, 2014, 2, 1, 97

    CrossRef

  7. 7
    Yogita K Adlakha, Neeru Saini, Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128, Molecular Cancer, 2014, 13, 1, 33

    CrossRef

  8. 8
    Jelle Praet, Caroline Guglielmetti, Zwi Berneman, Annemie Van der Linden, Peter Ponsaerts, Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis, Neuroscience & Biobehavioral Reviews, 2014, 47, 485

    CrossRef

  9. You have free access to this content9
    Nellie A. Martin, Zsolt Illes, Differentially expressed microRNA in multiple sclerosis: A window into pathogenesis?, Clinical and Experimental Neuroimmunology, 2014, 5, 2
  10. 10
    Marloes Prins, Ranjan Dutta, Bart Baselmans, John J P Brevé, John G J M Bol, Sadie A Deckard, Paul van der Valk, Sandra Amor, Bruce D Trapp, Helga E de Vries, Benjamin Drukarch, Anne-Marie van Dam, Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients, Acta Neuropathologica Communications, 2014, 2, 1, 98

    CrossRef

  11. 11
    Wen-Hsuan Huang, Hsu-Wen Chao, Li-Yun Tsai, Ming-Hung Chung, Yi-Shuian Huang, Elevated activation of CaMKIIα in the CPEB3-knockout hippocampus impairs a specific form of NMDAR-dependent synaptic depotentiation, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  12. 12
    Patrizia LoPresti, Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis, Neurochemical Research, 2014,

    CrossRef

  13. 13
    Andrew E Arrant, Erik D Roberson, MicroRNA-124 modulates social behavior in frontotemporal dementia, Nature Medicine, 2014, 20, 12, 1381

    CrossRef

  14. 14
    Guilherme Shigueto Vilar Higa, Erica de Sousa, Lais Takata Walter, Erika Reime Kinjo, Rodrigo Ribeiro Resende, Alexandre Hiroaki Kihara, MicroRNAs in Neuronal Communication, Molecular Neurobiology, 2014,

    CrossRef

  15. 15
    Andrea de Bartolomeis, Felice Iasevoli, Carmine Tomasetti, Elisabetta F. Buonaguro, MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective, Molecular Neurobiology, 2014,

    CrossRef

  16. 16
    Edith Sturm, Nadia Stefanova, Multiple System Atrophy: Genetic or Epigenetic?, Experimental Neurobiology, 2014, 23, 4, 277

    CrossRef

  17. 17
    Felix Luessi, Tanja Kuhlmann, Frauke Zipp, Remyelinating strategies in multiple sclerosis, Expert Review of Neurotherapeutics, 2014, 14, 11, 1315

    CrossRef

  18. 18
    Haiyang Xu, Jingjing Zhang, Wei Zhou, Yazhen Feng, Shiyong Teng, Xuesong Song, The role of miR-124 in modulating hippocampal neurotoxicity induced by ketamine anesthesia, International Journal of Neuroscience, 2014, 141114023202009

    CrossRef

  19. 19
    Christiane Wegner, Recent insights into the pathology of multiple sclerosis and neuromyelitis optica, Clinical Neurology and Neurosurgery, 2013, 115, S38

    CrossRef